Literature DB >> 31246795

Predictors for Prolonged Drainage following Tissue Expander-Based Breast Reconstruction.

Kyeong-Tae Lee1, Seung Heon Hong1, Byung-Joon Jeon1, Jai Kyong Pyon1, Goo-Hyun Mun1, Sa Ik Bang1.   

Abstract

BACKGROUND: A closed-suction drain is usually inserted during tissue expander-based breast reconstruction. Prolonged duration of drain retention can disturb patients' daily lives and affect overall sociomedical costs. This study aimed to investigate factors that may influence the drainage and to identify predictors of unusually prolonged drain duration.
METHODS: Patients who underwent delayed-immediate, two-stage breast reconstruction using a tissue expander between January of 2013 and July of 2017 were reviewed. Prolonged drain duration was defined as drain duration for longer than the 75th percentile of that for the entire cohort. Effects of patient- and operation-related variables on drainage and prolonged drain duration were evaluated.
RESULTS: A total of 1056 cases (1002 patients) were analyzed. The median drain duration was 10 days. Drain placement for more than 12 postoperative days was observed in 256 cases (24.2 percent), classified as prolonged drain duration. Multivariate analyses demonstrated that old age, high body mass index, neoadjuvant chemotherapy, insertion of large Siltex textured tissue expanders, and greater volume of initial inflation were independent risk factors of prolonged drain duration. The size and texture of the tissue expanders and initial inflation volume retained their influence, regardless of mastectomy specimen weight. Use of acellular dermal matrix had contradictory effects according to breast size, being protective against prolonged drain duration in cases with mastectomy specimen weight greater than 400 g, and being a significant predictor for it in cases with mastectomy specimen weight less than or equal to 400 g.
CONCLUSION: Several factors, including reconstructive operation-related factors, might influence drain duration following tissue expander-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Year:  2019        PMID: 31246795     DOI: 10.1097/PRS.0000000000005697

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Analysis of factors influencing postoperative drainage time in breast cancer.

Authors:  Quanyi Long; Jia Zhang; Jiahao Qi; Yuan Fan; Hongjiang Li
Journal:  Gland Surg       Date:  2021-12

2.  Direct comparison of CGCRYODERM and DermACELL in the same patient for outcomes in bilateral implant-based breast reconstruction: a retrospective case series.

Authors:  Sungmi Jeon; Jeong Hyun Ha; Ung Sik Jin
Journal:  Gland Surg       Date:  2021-07

3.  DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review.

Authors:  Austin R Swisher; Mark J Landau; Nikita Kadakia; Stephanie W Holzmer; Hahns Y Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-20

4.  Toward Drainless Breast Reconstruction: A Pilot Study.

Authors:  Harsh Patel; David Kulber; Edward Ray
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-10-17

5.  Comparison of Outcomes in Immediate Implant-Based Breast Reconstruction: Acellular Dermal Matrix versus Inferior Dermal Flap.

Authors:  Luís Mata Ribeiro; Rita P Meireles; Irís M Brito; Patrícia M Costa; Marco A Rebelo; Rui F Barbosa; Miguel P Choupina; Carlos J Pinho; Matilde P Ribeiro
Journal:  Arch Plast Surg       Date:  2022-04-06

6.  Drain Removal Time in Pre-pectoral versus Dual Plane Prosthetic Breast Reconstruction following Nipple-sparing Mastectomy.

Authors:  Hannah K Moriarty; Nusaiba F Baker; Alexandra M Hart; Grant W Carlson; Albert Losken
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-23

7.  Comparison of 30-day Clinical Outcomes with SimpliDerm and AlloDerm RTU in Immediate Breast Reconstruction.

Authors:  Brian P Tierney
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.